Plasma proteomics identifies potential drug targets for diabetic polyneuropathy: Evidence from prospective cohorts and genetic analysis
TNFRSF14 emerges as a promising biomarker and therapeutic target for the early detection and specific treatment of DP, paving the way for improved patient outcomes.
Authors
- Zhong Feng
- Haoning Lan (ORCID: https://orcid.org/0009-0009-6920-8081)
- Songchao Xu (ORCID: https://orcid.org/0000-0002-4277-0076)
- Yun Wang (ORCID: https://orcid.org/0000-0003-0695-8861)
- Huili Li (ORCID: https://orcid.org/0000-0002-9248-0720)
- Danxu Ma
- Ruijuan Guo (ORCID: https://orcid.org/0000-0003-0653-1059)
Institutions
- Capital Medical University (CN)
- Beijing Friendship Hospital (CN)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-10-27
- DOI
- https://doi.org/10.1111/dom.70239
- Primary Topic
- Pain Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00